This fall six new West Virginia University students with intellectual and developmental disabilities are paving the way for future students to be able to go to college, live on campus and gain academic and career preparation.
A new, biennial West Virginia population-based health survey—the Mountain State Assessment of Trends in Community Health—will gather information to help health officials and policy makers better understand the critical health needs of all 55 West Virginia counties, with the goal of directing resource allocations to communities that need them most.
About 90% of Americans who need treatment for a substance use disorder don’t get it. West Virginia University researchers have developed a program that allows people who have already walked the path of substance use disorder through recovery to be their guides to a healthier life.
The vast majority of people who overdose on an opioid will survive the experience. Yet scientists know little about how nonfatal overdoses affect the brain and cognition. WVU School of Medicine researchers Erin Winstanley and James Mahoney systematically reviewed journal articles that examined the topic. Overall, the studies supported a link between overdose, brain abnormalities and cognitive impairment, but more research—with more precision—is needed. Their findings appear in Drug and Alcohol Dependence.
WVU researchers are monitoring wastewater for COVID-19 concentrations and thanks to a nearly $3 million grant will develop a testing network throughout the state. The new testing process has possibilities beyond the pandemic to test for influenza, RSV, HIV and other viruses, as well as signs of antibiotic-resistance genes.
As a new semester begins, West Virginia University is increasing services to address students’ emotional and mental health needs and promote the awareness of resources available.
Just like the COVID-19 vaccine protects against contracting the contagious virus, the collective elements of self-efficacy, optimism, hope and resiliency helps inoculate employees from the negative effects of working through a pandemic, according to a new West Virginia University study.
West Virginia University issued a statement on Monday (Aug. 23) after the Federal Drug Administration fully approved the Pfizer COVID-19 vaccine.
Heath Damron and his colleagues at WVU are continuing to evaluate the nasal mist vaccine against currently circulating strains including the delta variant. The team is looking for commercial partners to help facilitate production at scale and further clinical evaluation.
Jonathan Boyd—a West Virginia University School of Medicine researcher—is investigating the inflammatory responses produced by exposure to chemical agents. The Defense Threat Reduction Agency recently awarded him over $2 million for the project.